editorrhinoviru
rv
common
caus
agent
acut
infect
addit
common
cold
rv
infect
associ
acut
otiti
media
sinus
bronchiol
asthma
pneumonia
sever
infect
especi
immunocompromis
patient
rv
infect
patient
chronic
obstruct
pulmonari
diseas
may
caus
mortal
otherwis
healthi
subject
rv
shed
last
day
antivir
drug
rv
infect
clinic
use
shown
rv
may
induc
persist
lower
respiratori
tract
infect
patient
hypogammaglobulinemia
addit
chronic
rv
infect
report
lung
transplant
recipi
cystic
fibrosi
rv
observ
suscept
action
interferon
ribavirin
potenti
antivir
effect
interferon
treat
rv
infect
patient
hypogammaglobulinemia
pegyl
interferon
ribavirin
three
adult
patient
common
variabl
immunodefici
diseas
adult
patient
xlink
agammaglobulinemia
tabl
despit
receipt
adequ
immunoglobulin
replac
therapi
histori
recurr
chronic
rv
infect
episod
earlier
rv
infect
patient
serv
selfcontrol
studi
durat
rv
shed
treatment
three
patient
develop
bronchiectasi
time
treatment
patient
respiratori
symptom
case
rv
detect
cultur
sputum
specimen
polymeras
chain
reaction
analysi
nasal
swab
sputum
specimen
patient
provid
oral
inform
consent
treat
pegyl
interferon
pegasi
roch
welwyn
garden
citi
unit
kingdom
subcutan
weekli
mg
ribavirin
rebetol
msd
hertfordshir
unit
kingdom
oral
twice
daili
week
found
interferon
ribavirin
treatment
associ
rapid
decreas
clearanc
rv
rna
case
episod
compar
selfcontrol
episod
efficaci
treatment
exemplifi
rapid
increas
blood
antivir
mxa
level
supplementari
figur
chronic
respiratori
symptom
concomit
use
antibiot
clinic
outcom
difficult
adjust
howev
patient
report
improv
qualiti
life
treatment
two
patient
report
fever
interferoninduc
advers
effect
note
patient
develop
rv
infect
month
complet
treatment
caus
increas
suscept
patient
hypogammaglobulinemia
rv
infect
unknown
low
level
mxa
treatment
suggest
defici
rvinduc
interferon
induct
report
subject
asthma
chronic
obstruct
pulmonari
diseas
hand
exogen
interferon
induc
good
level
mxa
suggest
normal
ifn
signal
pathway
interestingli
falzarano
et
al
recent
report
interferon
ribavirin
treatment
induc
distinct
gene
express
reduc
viral
replic
reduc
level
serum
lung
proinflammatori
marker
improv
clinic
outcom
middl
east
respiratori
syndrom
coronaviru
merscov
infect
rhesu
macaqu
preliminari
observ
small
group
patient
primari
hypogammaglobulinemia
falzarano
et
al
treatment
merscov
infect
vast
clinic
experi
treatment
chronic
hepat
c
viru
infect
suggest
effect
shortterm
pegyl
interferon
ribavirin
treatment
rv
infect
studi
especi
highrisk
group
intent
prescrib
preexposur
prophylaxi
associ
selfefficaci
norm
belief
editorw
read
interest
articl
karri
et
al
describ
although
major
north
american
infecti
diseas
physician
support
provis
human
immunodefici
viru
hiv
preexposur
prophylaxi
prep
atrisk
individu
strikingli
prescrib
prep
howev
remain
pauciti
data
regard
view
primari
care
provid
best
pois
prescrib
prep
atrisk
hivneg
patient
conduct
onlin
survey
decemb
understand
factor
associ
intent
prescrib
prep
among
physician
unit
state
use
model
base
theori
plan
behavior
hypothes
physician
intent
prescrib
prep
driven
attitud
selfefficaci
norm
belief
attitudin
question
assess
belief
regard
preprel
safeti
efficaci
adher
antiretrovir
resist
risk
compens
malpractic
insur
coverag
selfefficaci
question
evalu
physician
confid
identifi
atrisk
patient
prescrib
prep
monitor
patient
base
current
guidanc
center
diseas
control
prevent
cdc
norm
belief
assess
perceiv
peer
approv
prep
prescrib
good
intern
consist
domain
cronbach
composit
domain
score
divid
quartil
analysi
intent
prescrib
prep
assess
question
next
year
like
prescrib
prep
follow
patient
ask
popul
men
sex
men
msm
atrisk
women
hivuninfect
patient
serodiscord
relationship
compar
respond
like
respond
somewhat
like
like
best
character
earli
adopt
prep
prescrib
email
messag
link
survey
supplementari
figur
sent
physician
metropolitan
area
highest
hiv
incid
select
american
medic
associ
physician
masterfil
remind
request
week
physician
open
least
invit
email
click
survey
link
inelig
involv
direct
patient
care
relat
specialti
complet
survey
cooper
rate
click
survey
link
like
year
old
vs
p
infecti
diseas
physician
vs
p
major
respond
primari
care
provid
privat
practic
sampl
includ
physician
practic
famili
medicin
intern
medicin
obstetricsgynecolog
infecti
diseas
averag
patient
popul
femal
msm
hivinfect
hivserodiscord
relationship
provid
heard
prep
nearli
half
awar
cdc
guidanc
prep
care
patient
prescrib
prep
overal
physician
report
would
will
prescrib
prep
msm
atrisk
women
hivneg
patient
serodiscord
relationship
next
year
use
multipl
logist
regress
estim
intent
prescrib
prep
base
domain
quartil
score
adjust
signific
covari
p
univari
analys
care
patient
prep
postexposur
prophylaxi
selfefficaci
norm
belief
score
highest
quartil
independ
associ
intent
prescrib
prep
wherea
attitud
covari
tabl
given
multipl
barrier
identifi
karri
et
al
studi
provid
insight
could
guid
develop
evidencebas
intervent
increas
prep
prescrib
data
support
intervent
increas
clinician
selfefficaci
ie
onlin
risk
calcul
adher
monitor
tool
influenc
norm
belief
ie
comprehens
guidelin
endors
medic
societi
concur
conclus
karri
et
al
success
realworld
prep
like
requir
multifacet
approach
supplementari
materi
avail
clinic
infecti
diseas
onlin
http
cidoxford
